MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy

Cell Biology International
Li HuaJianguo Wei

Abstract

Non-small cell lung cancer (NSCLC) is a major type of lung cancer. Drug resistance is a enormous obstacle for cancer treatment. Copious microRNAs (miRNAs) have been demonstrated to be implicated in drug resistance in NSCLC. In the present study, RT-qPCR assay revealed that microRNA-1 (miR-1) expression was downregulated in DDP resistant NSCLC tissues and cells. Western blot assay presented a remarkable increase of LC3B-II/LC3B-I ratio and a notable decline of p62 level in DDP resistant NSCLC cells, while these effects were weakened by miR-1. GFP-LC3 puncta experiment showed that ectopic expression of miR-1 induced a noticeable downregulation of GFP-LC3 positive cell percentage in DDP resistant NSCLC cells. Bioinformatical analysis and luciferase assay revealed that autophagy related 3 (ATG3) was a target of miR-1. Also, Western blot and RT-qPCR assays manifested that ATG3 was highly expressed in DDP resistant NSCLC tissues and cells. Additionally, miR-1 inhibited ATG3 expression and ATG3 upregulation abolished miR-1-meidated autophagy inhibition in DDP resistant NSCLC cells. Cell Counting Kit-8 (CCK-8) assay showed that the half maximal inhibitory concentration (IC50 ) of cisplatin (DDP) was reduced in miR-1-enforced DDP resist...Continue Reading

References

Sep 8, 2006·The New England Journal of Medicine·Ken A OlaussenUNKNOWN IALT Bio Investigators
Jun 7, 2007·Journal of the National Cancer Institute·Andrea ArdizzoniUNKNOWN CISCA (CISplatin versus CArboplatin) Meta-analysis Group
Jan 12, 2008·Molecular Cancer Therapeutics·Paul E BlowerWolfgang Sadee
Aug 4, 2009·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Henk J BroxtermanHenk M W Verheul
Mar 2, 2010·Cancer Biotherapy & Radiopharmaceuticals·Jing-Hua RenGang Wu
Feb 19, 2011·Journal of Experimental & Clinical Cancer Research : CR·Hai-Bo BianWei De
Aug 2, 2011·Annual Review of Cell and Developmental Biology·Noboru MizushimaYoshinori Ohsumi
Sep 1, 2011·Molecular Cancer Therapeutics·Zhineng J YangFrank A Sinicrope
Nov 9, 2011·Journal of Biomedical Science·Cheng-Der WuChin-Tarng Lin
Nov 25, 2011·BMC Medical Genomics·Chang Hee KimJeffrey E Green
Jan 27, 2012·Molecular and Cellular Biochemistry·Buntitabhon SirichanchuenPithi Chanvorachote
Feb 22, 2012·EMBO Molecular Medicine·Marilena V Iorio, Carlo M Croce
Apr 27, 2012·Nature Reviews. Cancer·Eileen White
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S PetersUNKNOWN ESMO Guidelines Working Group
Jan 25, 2014·Cancer Research·David A Gewirtz
May 23, 2014·Current Pharmaceutical Biotechnology·Christian RolfoElisa Giovannetti
Jun 21, 2014·BioMed Research International·Chao HanQuancheng Kan
Jul 25, 2014·European Journal of Pharmacology·Shaloam Dasari, Paul Bernard Tchounwou
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jun 4, 2015·Oncotarget·Jesús García-CanoRicardo Sánchez-Prieto
Dec 17, 2015·Advances in Experimental Medicine and Biology·Lindsey A TorreAhmedin Jemal
Feb 1, 2018·Oncotarget·Irina FadejevaAndelko Hrzenjak

❮ Previous
Next ❯

Citations

Jan 16, 2019·Cellular Oncology (Dordrecht)·Safieh Ebrahimi, Seyed Isaac Hashemy
Mar 26, 2019·Acta Biochimica Et Biophysica Sinica·Xiaomin LiuYanyun He
May 8, 2020·Molecular Medicine Reports·Jing PengJinsong Lu
Aug 1, 2020·Frontiers in Oncology·Franz GeisslingerKarin Bartel
Jun 20, 2020·Expert Opinion on Therapeutic Targets·Shanshan WangGeorge G Chen
Dec 15, 2020·European Journal of Pharmacology·Milad AshrafizadehMasoud Najafi
Dec 23, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Kanghong XuYi Zhang
May 27, 2021·Seminars in Cell & Developmental Biology·Parvez KhanMohd Wasim Nasser
Jul 9, 2021·Frontiers in Cell and Developmental Biology·Dongmei FangMin Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Related Papers

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Jie BaoJiansheng Li
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban
Yu-Mei RaoCai-Hong Chen
© 2022 Meta ULC. All rights reserved